28 Aug 2020 15:27
Collagen Solutions plc
(the "Company")
Director/PDMR Dealing
1. Vesting / exercise of Deferred Bonus Awards granted in October 2019
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that, on 28 August 2020, the executive director and other persons discharging managerial responsibility ("PDMRs") set out in the table below acquired ordinary shares of 1 pence each in the share capital of the Company ("Shares") pursuant to the vesting / exercise of awards originally granted under the Collagen Solutions plc Deferred Bonus Plan on 2 October 2019 (the "Awards"). No consideration was payable for these Shares.
Director/PDMR | Position | Number of Shares acquired on 28 August 2020 |
Jamal Rushdy | Chief Executive Officer | 906,145 |
Lou Ruggiero | Chief Business Officer | 806,559 |
Brad Selman | PDMR / VP Global Sales and Marketing | 284,202 |
Chris Wattengel | PDMR / VP Global R&D | 246,514 |
Kevin Darling | PDMR / VP Tissue Products | 173,596 |
Notes:
1 A number of other individuals, including Hilary Spence, Chief Financial Officer, were also granted Awards under the Deferred Bonus Plan on 2 October 2019. Although these Awards (which are in the form of "nil-cost" options) have now vested, the relevant holders have not yet elected to exercise their rights and acquire their Shares.
The Shares required to satisfy the above vestings / exercises were transferred to the relevant individuals by the trustee of the Collagen Solutions plc Employee Benefit Trust (the "EBT"). As previously announced, these Shares were allotted to the EBT on 11 August 2020.
2. Total beneficial holdings in the Company
Following the above notifications, the total holdings of Shares of the relevant PDMRs are as follows:
Director/PDMR | Position | Total holding following this notification | Approximate % of the Company's issued share capital |
Jamal Rushdy | Chief Executive Officer | 1,906,145 | 0.43% |
Lou Ruggiero | Chief Business Officer | 806,559 | 0.18% |
Brad Selman | PDMR / VP Global Sales and Marketing | 284,202 | 0.06% |
Chris Wattengel | PDMR / VP Global R&D | 246,514 | 0.06% |
Kevin Darling | PDMR / VP Tissue Products | 173,596 | 0.04% |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||||||||||||
a) | Name | 1. Jamal Rushdy 2. Lou Ruggiero 3. Brad Selman 4. Chris Wattengel 5. Kevin Darling | ||||||||||||||||||
2 | Reason for the notification | |||||||||||||||||||
a) | Position/status | 1. Chief Executive Officer 2. Chief Business Officer 3. PDMR / VP Global Sales and Marketing 4. PDMR / VP Global R&D 5. PDMR / VP Tissue Products | ||||||||||||||||||
b) | Initial notification/ Amendment | Initial Notification | ||||||||||||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||
a) | Name | Collagen Solutions plc | ||||||||||||||||||
b) | LEI | 213800IFY1CVGRGETL95 | ||||||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of 1p each ("Shares") | ||||||||||||||||||
Identification code | ISIN Code: GB00B94T6Y14 | |||||||||||||||||||
b) | Nature of the transaction | Acquisition of Shares on the vesting / exercise of Awards originally granted on 2 October 2019 pursuant to the Collagen Solutions plc Deferred Bonus Plan | ||||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||||
d) | Aggregated information - Aggregated volume - Price | 1. N/A single transaction 2. N/A single transaction 3. N/A single transaction 4. N/A single transaction 5. N/A single transaction | ||||||||||||||||||
e) | Date of the transaction | 2020-08-28 | ||||||||||||||||||
f) | Place of the transaction | Outside a trading venue | ||||||||||||||||||
Enquiries:
Collagen Solutions Plc | |||||
Jamal Rushdy, CEO |
| ||||
Hilary Spence, CFO | Via Walbrook | ||||
Cenkos Securities Plc (Nominated Adviser and Broker) | |||||
Giles Balleny (Corporate Finance) | Tel: 0207 397 8900 | ||||
Stephen Keys | |||||
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com | ||||
Anna Dunphy | Mob: 07876 741 001 | ||||